For those of us in the field of finance, the last several weeks have been interesting – not to say hair-raising – ones with regard to the financial and economic aspects of the coronavirus epidemic and a fortiori with the official, hyper-Lehman response to it.
Alongside these, much greater issues clearly lie. Obviously, one can only discuss the public health and medical elements of this episode from the perspective of an educated layman and so these will not be dealt with here in any detail. However, there are several salient points arising from these which it would be remiss not to remark upon, given that they have much wider implications, far beyond the epidemiological or clinical treatment of the current crisis. [PODCAST VERSION HERE]